HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier

Antiviral Therapy

Volumn 2, Issue 2, 1997, Pages 113-117

  Burger, David M ^a,c   Boucher, Charles A B ^b   Meenhorst, Pieter L ^a   Kraayeveld, Cees L ^a   Portegies, Peter ^b   Mulder, Jan W ^a   Hoetelmans, Richard M W ^a   Beijnen, Jos H ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

ADULT; AIDS DEMENTIA COMPLEX; BLOOD-BRAIN BARRIER; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0030962153     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chiodi F, Keys B, Albert J, Hagberg L, Lundeberg J, Uhlen M, Fenyo EM & Norkrans G. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. Journal of Clinical Microbiology 1992; 30:1768-1771.
2. Schmid P, Conrad A, Syndulko K, Singer EJ, Handley D, Li X, Tao G, Fahy-Chandon B & Tourtellotte WW. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurological abnormalities. Journal of Acquired Immune Deficiency Syndromes 1994; 7:777-788.
3. Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA & Hamilton JD. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. Journal of Infections Diseases 1990; 161:1068-1072.
4. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheimvan Dillen PME & van der Noordaa J. Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 1990; 28:495-503.
5. Mulder J, McKinney N, Cristopherson C, Sninsky J, Greenfield L & Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. Journal of Clinical Microbiology 1994; 32:292-300.
6. Price RW. Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS 1995; 9 (Supplement A):S221-S236.
7. Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil A & Simmonds P. Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994; 343:382-385.
8. Spector SA, Hsai K, Pratt D, Lathey J, McCutchan A, Alcaraz JE, Atkinson JH, Gulevich S, Wallace M, Grant I & the HIV Neurobehavioral Research Center Group. Virologie markers of human immunodeficiency virus type 1 in cerebrospinal fluid. Journal of Infections Diseases 1993; 168:68-74.
9. Petito CK & Cash KS. Blood-brain abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum protein in postmortem brains. Annals of Neurology 1992; 32:658-666.
10. Conrad AJ, Schmid P, Syndulko K, Singer EJ, Nagra RM, Russell JJ & Tourtellotte WW. Quantifying HIV-1 RNA using polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995; 10:425-435.
11. Burger DM, Kraaijeveld CL, Meenhorst PL, Mulder JW, Koks CHW, Bull A & Beijnen JH. Penetration of ridovudine into the cerebrospinal fluid of patients infected with HIV. AIDS 1993; 7:1581-1587.